PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 2092805
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 2092805
Chemical Peel market size was valued at US$ 2,401.9 Million in 2025, expanding at a CAGR of 5.6% from 2026 to 2033.
The chemical peel process is very controlled because the process uses the Type of acids to remove the old and dead skin cells while stimulating the growth of new skin cells. The general procedure of this process includes several steps such as pre-peeling preparation; Type of the necessary chemicals such as AHAs, TCA, and phenol with the right concentrations and pH to define its depth, which could be superficial, medium, or deep depending on the required results; and finally, controlling the dwell time in order to penetrate through the layers of the skin.
Chemical Peel Market- Market Dynamics
Rising Demand for Minimally Invasive Cosmetic Dermatology Procedures to Drive Market Growth
Rising demand for minimally invasive cosmetic dermatology procedures is driving the growth of the Chemical Peel market because of growing preferences for non-surgical skin rejuvenation procedures among consumers. For instance, in 2026, according to JMIR Org Medical Informatics, public interest in the use of fractional CO2 laser treatment increased by 354% in Germany between 2020 and 2025, as measured by an increase in the baseline score on Google Trends from 15.0 in 2020 to 68.1 in 2025. It was found that there was a statistically significant seasonality (P < 0.001), where demand reached a peak during winter months owing to the rising use of minimally invasive cosmetic dermatology procedures among consumers. . This trend is expected to sustain market expansion through continued adoption of advanced skin resurfacing treatments.
The Global Chemical Peel market is segmented on the basis of Product, Type, Application, End Use, and Region.
The Lactic Peel segment holds a prominent share because of its effective exfoliation, safety for sensitive skin, and extensive Type in skin improvement and hydration. For instance, in 2025, according to a randomized clinical study published in the Indian Dermatology Online Journal, 90% lactic acid peel showed high efficiency in epidermal melasma treatment in 2025. The experiment involved 60 people, and they were randomly divided into two groups; one group used 90% lactic acid peeling two times every two weeks for 12 weeks. Good results were obtained by 63.3% of patients, very good results were seen in 6.7% of patients, 13.3% of patients suffered from mild burning, and 3.3% of patients had post-inflammatory hyperpigmentation. This approach delivers noticeable skin rejuvenation while supporting safe, consistent, and predictable clinical outcomes.
Chemical Peel Market- Geographical Insights
North America held a significant share in the Chemical Peel market because of the growing need for minimally invasive cosmetic procedures and increasing awareness regarding advanced cosmetic treatments. For instance, in 2026, according to the American Academy of Dermatology (AAD), acne is expected to be the most common skin condition in the US, which is prevalent among up to 50 million people in the country every year, out of whom around 85% suffer from a mild form of acne among the people between ages 12 and 24. Furthermore, adult acne affects up to 15% of women. This sustained demand continues to reinforce regional growth in the chemical peel market.
The UK is one of the countries where a considerable portion of market share is occupied by chemical peel treatments because of the growing trend of rejuvenating facial treatments and the presence of aesthetic services. For example, in 2025, in an article published in PMC (PubMed Central), it was found that in the UK, there were 3,056 providers of aesthetic medicine who practised botulinum toxin-based facial rejuvenation therapies at 2,018 clinics. The availability of such services in the nation, in addition to costs of between USD 125-438 per procedure, demonstrates the rising demand for minimally invasive facial rejuvenation treatment due to the rising awareness about aesthetics and consumer inclination towards non-surgical cosmetic procedures. This expanding aesthetic treatment landscape continues to support sustained demand for chemical peel procedures across the country.
The competitive landscape in the Chemical Peel market involves tough competition from market leaders like Allergan (US), Galderma (Switzerland), Revance Therapeutics (US), PCA Skin (US), and SkinMedica (US), who are emphasising innovation, formulation, and aesthetics. Some of the developments that have taken place with the firm due to customer preferences for professional skin care products in the aspects of research & development, partnership, and Application to establish a strong position in the market. In January 2025, Allergan (US) introduced its AA Signature Program at IMCAS 2025 and showcased its patient-orientated multimodal approach in its aesthetic process. Collectively, these initiatives continue to reinforce competitive differentiation and support sustained market development.
In February 2025, Revance Therapeutics (US) completed its acquisition by Crown Laboratories, combining Revance's aesthetics portfolio with Crown's dermatology business to strengthen innovation and commercialisation capabilities across aesthetic and skincare solutions.